Dibavog GM 1mg/500mg/0.2mg Tablet
Marketer
Kasdap Healthcare Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Dibavog GM 1mg/500mg/0.2mg Tablet
Glycemia-Control 1mg/500mg/0.2mg tablets are classified as antidiabetic agents. This combination medication manages type 2 diabetes in adults by regulating blood glucose. Administer this medication orally with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled glucose levels. Premature discontinuation, without medical consultation, risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. This medication is part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential to mitigate this risk. Alcohol consumption should be avoided due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.
Uses of Dibavog GM 1mg/500mg/0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Dibavog GM 1mg/500mg/0.2mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Dibavog GM 1mg/500mg/0.2mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication on an empty stomach.
Common Side effects of Dibavog GM 1mg/500mg/0.2mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Dibavog GM 1mg/500mg/0.2mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the Dibavog GM 1mg/500mg/0.2mg Tablet whole; avoid chewing, crushing, or fracturing it. Consumption should occur on an empty stomach.
How Dibavog GM 1mg/500mg/0.2mg Tablet works:
Each Dibavog GM tablet (1mg/500mg/0.2mg) contains a triple-action formulation to manage diabetes.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Dibavog GM 1mg/500mg/0.2mg tablets is unsafe.
PregnancyCONSULT YOUR DOCTOR
Use of Dibavog GM 1mg/500mg/0.2mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any risks before prescribing. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Dibavog GM 1mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Dibavog GM 1mg/500mg/0.2mg tablets in patients with kidney impairment carries a high risk and is best avoided. Patients with severe kidney disease should definitely not take this medication. Medical advice is recommended.
LiverCAUTION
Patients with liver impairment should use Dibavog GM 1mg/500mg/0.2mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate hepatic dysfunction, initiation with a reduced dose is typical; however, the medication is contraindicated in cases of severe liver disease.
What if you forget to take Dibavog GM 1mg/500mg/0.2mg Tablet :
Should you forget a Dibavog GM 1mg/500mg/0.2mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dibavog GM 1mg/500mg/0.2mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently